Lyme Disease Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies - LyGenesis, Inc.

(Las Vegas, Nevada, United States) DelveInsight's "Lyme Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Lyme Disease, historical and forecasted epidemiology as well as the Lyme Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Download Sample Report to know more
@https://www.delveinsight.com/sample-request/lyme-disease-ld-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Lyme Disease Overview
Lyme disease also known as Lyme borreliosis is the most common vector-borne disease caused by the bacterium Borrelia burgdorferi and rarely, Borrelia mayonii. It is a common disease in the US and is caused by the bite of an infected black-legged tick (also known as the deer tick or bear tick). The disease affects both humans and animals.
The stages include:
Early localized Lyme Disease ; Early Disseminated Lyme Disease; Late Lyme Disease
Symptoms of Lyme Disease depend on the stage of disease, however, some of the most common symptoms include Arthritis, Neurological symptoms, Eye Inflammation, Fatigue, Sleep Disturbance, Stiff Neck, Fever, Erythema, Migrans, and Body Aches.
Diagnosis
Lyme disease is often difficult as many of the symptoms are similar to other conditions. The most accurate way to detect Lyme disease is with a two-stage blood test. The first is a screening test called an enzyme-linked immunosorbent assay (often referred to as ELISA). The second test can be an immunoblot or another, different ELISA.
Treatment

A 10 to 14-day course of antibiotics is used to treat people who are diagnosed with early Lyme disease, with the duration
depending on the choice of drug. The choice of antibiotic depends on the stage of the disease and the symptoms. Some common
choices include doxycycline, amoxicillin, cefuroxime, and azithromycin. Later stages of Lyme disease are also often treated with
the same antibiotics for up to a month; intravenous ceftriaxone is sometimes needed for refractory arthritis or neurologic disease.
Click here to learn more about the Lyme Disease Market Landscape @https://www.delveinsight.com/report-store/lyme-disease-ld-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Key Highlights from Lyme Disease Market Report
There are about 300,000 to 500,000 cases which result in 5,000 deaths a year.One estimate places the number as high as 3 million cases per year.
Estimates of Lyme Disease are complicated by the lack of easy-available diagnosis, limited public health surveillance infrastructure, and high clustering of incidence near high-intensity sampling.
The infection affects females 1.2 times more than males. The age group predominantly infected is 21-30 years.
Lyme Disease Treatment Market
Ribavirin, an antiviral drug, has been used with success in Lyme Disease patients. It is most effective when given early in the course of the illness. Patients also receive supportive care consisting of maintenance of appropriate fluid and electrolyte balance, oxygenation, and blood pressure, as well as treatment of any other complicating infections. Primary transmission of the Lassa virus from its host to humans can be prevented by avoiding contact with Mastomys rodents, especially in the geographic regions where outbreaks occur.
Learn more about the treatment market for Lyme Disease @ https://www.delveinsight.com/report-store/lyme-disease-ld-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
The Report Covers the Lyme Disease Epidemiology Segmented by:
Lyme Disease prevalent cases
Lyme Disease Incident Cases
Lyme Disease treatment cases
Lyme Disease diagnosed cases
Lyme Disease Dug Profile and Companies Covered
LyGenesis, Inc.
And many others.
Learn more about the Key Companies and Emerging Therapies in the Lyme Disease Market @https://www.delveinsight.com/report-store/lyme-disease-ld-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Table of Contents
Key Insights
Lyme Disease Introduction
Executive Summary of Lyme Disease
Disease Background and Overview
Lyme Disease Epidemiology and patient population
Lyme Disease Emerging Therapies
Lyme Disease Market Outlook
Lyme Disease Market Access and Reimbursement of Therapies
Lyme Disease Market Drivers
Lyme Disease Market Barriers
Appendix
Lyme Disease Report Methodology
DelveInsight Capabilities
Disclaimer

Learn about the detailed offerings of the Lyme Disease Market Outlook report @ https://www.delveinsight.com/sample-request/lyme-disease-ld-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Related Reports
Lyme Disease Epidemiology Forecast
https://www.delveinsight.com/report-store/lassa-fever-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Lyme Disease Pipeline Forecast
https://www.delveinsight.com/report-store/lassa-fever-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

https://www.delveinsight.com

DelveInsight Business Research LLP
Adya Kaul
info@delveinsight.com
https://www.delveinsight.com

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.